Notice: WC_Cart::get_cart_url is deprecated since version 2.5! Use wc_get_cart_url instead. in /home/ebworldcongress/public_html/wp-includes/functions.php on line 3893

Global EB Alliance

The Global EB Alliance is a group of more than 20 rare disease and dermatology organisations worldwide supporting EB World Congress and the inaugural EB 2020 event.


DEBRA UK is the UK charity supporting people suffering from Epidermolysis Bullosa (EB) – a potentially fatal skin condition that causes constant pain due to unstoppable internal and external blistering.

  • We fund pioneering research for symptom alleviation and, ultimately, a cure.
  • We provide life changing care and support to the EB Community.

Together we #FightEB, together we will beat EB.

Visit to learn more.

Cure EB

Cure EB exists to treat and cure epidermolysis bullosa, a genetic skin condition that leads to blistering and skin loss with the mildest friction.

It is “Hard to say. Hell to live with” and children and adults with the condition live in constant pain associated with the burn like wounds that occur. The intense pain and repeated damage leads to progressive disability and severe forms are life shortening due to a particularly aggressive skin cancer that develops in early adulthood. We have a focus on accelerating research to cure all forms of EB. Research is targeted at gene modifying and corrective strategies that aim for translation into effective treatments and eventual cures. Our relationships with academia and research scientists, other non profits, foundations, companies and the biotech industry will help us achieve our goal.


Acta Dermato-Venereologica is an international peer-reviewed journal for clinical and experimental research in the field of dermatology and venereology. It publishes high-quality manuscripts in English dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume features a number of Review articles in special areas, Original reports and Short Communications to stimulate debate and to disseminate important clinical observations.

Visit to learn more.


The mission of the ASMB is to promote basic, translational, and clinical research on the extracellular matrix (ECM), cell-ECM interactions, and ECM-based therapies and devices, and to support the growth and professional development of the ECM research community. The ASMB promotes interactions among academia, scientific societies, industry, and government; facilitating dissemination of relevant knowledge and new findings; providing mentoring opportunities to junior scientists; and advocating sustained funding for research and education. Each year ASMB offers travel awards and hosts either regional workshops or a larger conference.

Visit the ASMB website for more information about the society and upcoming events.

British Skin Foundation

The British Skin Foundation are the only UK charity that raises money to fund research into all types of skin diseases, including skin cancer.

Sixty percent of British people currently suffer from or have suffered with a skin disease at some point during their lifetime. Whilst some skin conditions are manageable, others are severe enough to kill.

We are here to help change that by raising money for vital research to help find cures and treatments for common skin conditions like eczema or acne, through to potential killers like malignant melanoma.

Founded in 1996, the British Skin Foundation has supported 400 research projects and awarded £16,000,000 in funding across all skin diseases.

Whilst we are dedicated to raising money for research, we also aim to raise awareness of skin diseases in the wider community. We're committed to educating people about the different skin conditions, helping to reduce stigma and promote understanding.

The British Skin Foundation receives no statutory funding and relies on completely on donations. Find out more about our research here.

DEBRA of America

The Dystrophic Epidermolysis Bullosa Research Association of America (debra of America) is the only U.S. nonprofit providing all-inclusive support to the EB Community, through funding research for a cure and by providing free programs and services for those with: Epidermolysis Bullosa (EB) — "The Worst Disease You've Never Heard Of."

Visit to learn more.

DEBRA Austria

DEBRA Austria is the Austrian national charity that supports individuals and families affected by EB – a painful genetic skin blistering condition which, in the worst cases, can be fatal.

DEBRA Austria was founded in 1995 by parents of children with EB and is founding member of DEBRA International, a worldwide network of more than 50 national patient support groups.

Our key activities are…
  • We provide care and support to improve the quality of life for individuals and families living with EB.
  • We established and run the world’s first dedicated EB clinic, the EB Haus Austria: outpatient unit, research unit, study centre and academy.
  • We fund excellent research around the globe to find effective treatments and, ultimately, a cure for EB.

Visit to learn more.

DEBRA International

DEBRA International is the world’s leading epidermolysis bullosa (EB) patient advocacy and support network. DEBRA International is the central body for the network of more than 50 national DEBRA groups, fostering collaboration on international projects to avoid duplication of efforts and cost. Whilst the primary focus of DEBRA groups is to support their national EB Communities, DEBRA International provides support in territories where there is a lack of EB knowledge. DEBRA International collaborates with the DEBRA network across research, clinical practice guidelines, developing-country support, grants, an EB patient registry, and EB-related events.

Visit to learn more.


EB-CLINET is a clinical network of EB centres and experts, which aims at establishing EB centres worldwide to improve medical care for people with EB through exchange of knowledge and experience about EB and, by providing a basis for clinical trials, to accelerate the way to a cure for this disease.

Visit to learn more.


EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of 826 rare disease patient organisations from 70 countries that work together to improve the lives of the 30 million people living with a rare disease in Europe.

By connecting patients, families and patient groups, as well as by bringing together all stakeholders and mobilising the rare disease community, EURORDIS strengthens the patient voice and shapes research, policies and patient services.

Visit to learn more.


The ERN-Skin gathers doctors and researchers who join their efforts to improve the diagnosis and management of all the patients suffering from rare, complex and undiagnosed skin diseases. It is composed of 56 reference centres located in 18 different countries.

The ERN-Skin was created in 2017 along with 23 European Reference Networks (ERNs) which mark the start of a new cooperation in the field of health in Europe.

Visit to learn more.


Findacure is a UK-based charity which is building the rare diseases community to drive research and develop treatments. Our vision is a world in which all rare diseases have treatments - made together with patients, for patients.

To achieve our vision, we provide free training to improve the skills, knowledge and confidence of those leading patient support groups. As evidenced here with EB 2020, patient groups are an incredibly powerful driving force when it comes to rare research. We want to see patient groups across the rare community doing what DEBRA is doing in their own disease area.

We also host conferences and "Showcases" to bring the wider rare disease community together - including researchers, academics and life sciences professionals - and run an annual essay competition to raise awareness among medical students.

Visit to learn more.


The European Wound Management Association (EWMA) is a European not-for-profit umbrella organisation, linking national wound management organisations, individuals and groups with interest in wound management.

Visit to learn more.

Genetic Disorders UK

Genetic Disorders UK is a registered charity with a vision to improve the lives of individuals and families affected by genetic disorders.

While individual genetic disorders are rare, it is thought that there are currently more than 6,000 diagnosed disorders and new disorders are being identified every day. It is estimated that 1 in 25 children is affected by a genetic disorder.

Our mission is to be the leading source of information and support for both those affected by a genetic disorder, and the charities and patient groups that support them, by bringing together everyone’s combined experience in a place it can be shared.

Visit to learn more.


Healx is a tech company focused on accelerating treatments for rare diseases. To achieve this we have developed the most comprehensive AI-based drug discovery platform for rare diseases: Healnet. By integrating artificial intelligence with deep pharmacology Healnet makes it possible to translate therapies into the clinic within 24 months, dramatically reducing the time and cost compared with conventional drug discovery methods. It's our mission to translate 100 rare disease treatments towards the clinic by 2025.

Visit to learn more.


LifeArc transforms great science into greater patient benefit. We are the medical research charity with a 25-year legacy of helping scientists and organisations turn their research into practical treatments and diagnostics. We bring together a network of partners to tackle specific diseases and to directly fund academic and early stage research. So far our work has helped to develop four marketed drugs (Keytruda®, Actemra®, Tysabri®, and Entyvio®).

Visit to learn more.


Hosted by trusted patient advocates, RareConnect is a place where Epidermolysis Bullosa patients and families can connect with others globally.

Visit to learn more.

Society for Investigative Dermatology

The Society for Investigative Dermatology (SID) was founded in 1937 to disseminate information on skin research, investigate new therapeutic options for skin disease, and nurture the next generation of Dermatologists and researchers. Each year, approximately 1200 abstracts of unpublished data, and dozens of invited thought leaders offer access to cutting edge Immunology, Cutaneous Oncology and Dermatology research over the course of the four-day SID annual meeting.

The SID is recognized as the premier forum for discovery, dissemination and exchange of skin research, with a significant portion of abstracts covering Inflammation, Autoimmunity and Cutaneous Oncology. This global meeting draws a diverse group of senior researchers and clinicians, as well as hundreds of clinical trainees including Dermatology residents. These healthcare professionals and basic researchers are on the frontline for recognizing systemic disease (including many types of cancer) with a skin-related association. In addition, presentations represent a diversity of specialties and disciplines, including Dermatology, Oncology, Cell Biology, Genetics, Pathology, Immunology, and Inflammation.

Visit to learn more.